Drug Type Fusion protein |
Synonyms |
Target |
Action modulators |
Mechanism IL-17R modulators(Interleukin-17 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | China | 13 Jun 2024 | |
Lymphopenia | Preclinical | China | 06 Jul 2022 | |
Neoplasms | Preclinical | China | 06 Jul 2022 |